Hi Larga
Bingo! ... yes you are correct ... so the per share price should be approx $0.36 for the Cardiocell line of business
Thanks larga for reading my calcs .... what do you think of the logic?
And if it is anywhere near correct logic for the valuation then we have a long way to go with this ..yes???
And I still cannot see why we are languishing at only 14 lousy cents!
regards
The science nerds need to step up, page-24
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.81 |
Change
-0.190(1.06%) |
Mkt cap ! $342.3M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $42.44K | 2.364K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $17.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.90 | 35 | 3 |
View Market Depth
| Last trade - 13.24pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |